Individuals with coronary artery disease exist on a spectrum of disease, such as the amount of plaque build-up in the arteries of the heart; however, the disease is conventionally classified as broad categories of case (yes disease) or control (no disease), which may result in misdiagnosis. A digital marker for coronary artery disease derived from machine learning and electronic health records can better quantify where an individual falls on the disease spectrum. Credit: Icahn School of Medicine at Mount Si
News | Heart Failure
Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

December 22, 2022 — Using machine learning and clinical data from electronic health records, researchers at the Icahn ...

Home December 22, 2022
Home
Collaborative team from Rockefeller University, Cleveland Clinic publish findings in Science
News | Coronavirus (COVID-19)
Research Identifies Potential Genetic Cause for MIS-C Complication Following COVID-19 Infection

December 22, 2022 — New research findings have revealed an underlying genetic cause for why some children who have had ...

Home December 22, 2022
Home
The Arrhythmia Care Team at Corewell Health Celebrate First Successful Procedures With New Genesis Robotic Cardiac Ablation System from Stereotaxis.
News
Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint
News | Cardiovascular Clinical Studies
CLEAR Outcomes Accepted as Late-Breaking Clinical Trial at ACC.23 Annual Scientific Session & Expo together with the World Congress of Cardiology

December 21, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...

Home December 21, 2022
Home
Robbin Cohen, MD, now serves as director of the Cardiac Surgery Program at Huntington Health, a Cedars-Sinai affiliate, and will be practicing out of Huntington Health’s Pasadena campus.
News | Cardiovascular Surgery
Cedars-Sinai Expands Cardiac Surgery at Huntington Health

December 21, 2022 — The Smidt Heart Institute at Cedars-Sinai is again expanding its geographic reach and surgical ...

Home December 21, 2022
Home
Arrow International, LLC, a Subsidiary of Teleflex, Inc, recalls Arrow AutoCAT 2, AC3 intra-aortic balloon pumps for unexpectedly short battery run times
Feature | Intra-Aortic Balloon Pumps (IABP)
Teleflex Recalls Arrow Intra-Aortic Balloon Pumps for Short Battery

The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Arrow AutoCAT 2 and AC3 Intra-Aortic ...

Home December 20, 2022
Home
Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.23/WCC) have been announced.
Feature | ACC | By Melinda Taschetta-Millane
ACC 2023 Late-breaking Clinical Trials Announced

Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World ...

Home December 20, 2022
Home
Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis
News | Artificial Intelligence
Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease

December 19, 2022 — Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has entered ...

Home December 19, 2022
Home
End-to-end platform tailored for the hospital’s vascular care team helps detect suspected vascular disease and improve patient outcomes
News | Artificial Intelligence
Delray Medical Center Advances its Endovascular Program as the First Hospital in Florida to Acquire the AI-Powered Viz Vascular Suite

December 19, 2022 — As a leader in vascular care, Delray Medical Center is the first hospital in Florida to acquire the ...

Home December 19, 2022
Home
suPAR overexpression leads to increased atherosclerotic and necrotic plaques in a murine model of atherosclerosis. WT (n = 18) and suPARTg (n = 21) mice were maintained on a low-fat diet until 3 months of age and were then transfected with Pcsk9-AAV and fed a western diet (WD) for 10 weeks. At this point, aortic roots were obtained, paraffin embedded, and stained with H&E and Mac2 (galectin 3). (A) Cross sections of aortic roots from C57BL/6 WT and suPARTg mice show total lesion area, outlined in dashed lin
News | Heart Failure
New Immune Target to Treat Cardiovascular Disease Discovered

December 16, 2022 — For the longest time, clinicians have treated cardiovascular disease by focusing on diabetes and ...

Home December 16, 2022
Home
From left, Craig Schumacher, Jake and Yvette Honda-Schumacher. Image courtesy of Cedars-Sinai
News | Pediatric Cardiology
A Heart Fix That Fits

December 16, 2022 — Yvette Honda-Schumacher was 20 weeks pregnant and had just had a routine anatomy ultrasound when she ...

Home December 16, 2022
Home
Innovative approach can deliver high-fidelity cardiopulmonary exercise test results comparable to gold-standard testing with a wearable sensor during routine daily activities
News | Remote Monitoring
physIQ’s eVO2Max Demonstrates Breakout Ability to Estimate Cardiopulmonary Functional Capacity from Wearable Sensor Data During Daily Routine Activity

December 15, 2022 — physIQ announced a novel approach to estimating maximum oxygen utilization (VO2Max) using wearable ...

Home December 15, 2022
Home
Doctors from the Emory Heart & Vascular Center are joining forces with the Family Heart Foundation, a leading research and advocacy organization, to find and more widely treat undiagnosed patients living with a common genetic condition that causes very high levels of unhealthy cholesterol, heightening the risk for heart attacks and strokes even at a young age.
News | STEMI
Emory Doctors and Family Heart Foundation Team Up to Help Patients with Dangerously High Cholesterol Caused by Genetic Condition

December 15, 2022 — Doctors from the Emory Heart & Vascular Center are joining forces with the Family Heart Foundation ...

Home December 15, 2022
Home
From left, Qian Ma, PhD, and Yuqing Huo, MD, PhD. Photo courtesy of Michael Holahan, Augusta University
News | Heart Failure
New Target in the Fight Against Heart Disease

December 15, 2022 — Soon after cholesterol and fat start depositing on the lining of the blood vessels that supply your ...

Home December 15, 2022
Home
Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping awareness about the extent and impact of underdiagnosis and undertreatment of aortic stenosis (AS).
News | Heart Valve Technology
Edwards Identifies Top Data Releases of 2022 that Highlight the Impacts of Aortic Stenosis Undertreatment

December 14, 2022 — Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping ...

Home December 14, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now